Frontiers in Neurology

Frontiers in Neurology is a neurology journal published from Lausanne by Frontiers Media SA, which has issued it since 2010 as one title in its open access series.《神经病学前沿》是 Frontiers Media SA 在洛桑出版的一份神经病学刊物，自 2010 年起作为该社开放获取丛书中的一种发行。

Its 2025 Journal Impact Factor is 3.3, which places the title in the second quartile of clinical neurology and of neurosciences alike.该刊 2025 年的影响因子为 3.3，在临床神经病学与神经科学两个类目中同列第二区。

No issues are numbered. Each calendar year opens a single volume, and every accepted article takes an article number of its own inside that volume.刊物不编期号，每个日历年只开一卷，文章录用后在卷内取得一个属于自己的编号。

Scope

• The journal calls itself multidisciplinary and takes in all areas of neurology in the interest of understanding, treating and preventing neurological disorders. It also names the United Nations Sustainable Development Goals among the ends it serves, the third on health and well-being first of all.刊物自述为多学科刊物，覆盖神经病学的全部领域，着眼点在于理解、治疗与预防神经系统疾病，并把联合国可持续发展目标列为服务对象，其中首先是健康与福祉方面的第三项。

• Cerebrovascular disease has two sections of its own, one for stroke and one for endovascular and interventional neurology, the second taking in thrombectomy and intra-arterial procedures.脑血管病设有两个栏目，一个专治卒中，一个管血管内与介入神经病学，后者涵盖取栓与动脉内操作。

• Epilepsy and sleep disorders are kept apart, the first taking seizure semiology, electroclinical diagnosis and surgical candidates, the second insomnia, sleep apnoea and the parasomnias.癫痫与睡眠障碍分属两栏，前者收发作学、电临床诊断与手术候选者，后者收失眠、睡眠呼吸暂停与异态睡眠。

• Movement disorders have a section of long standing, with Parkinsonian syndromes, dystonia, tremor and chorea among the conditions it covers.运动障碍是一个设立已久的栏目，帕金森综合征、肌张力障碍、震颤与舞蹈症都在其病种之列。

• Multiple sclerosis and neuroimmunology share one section, which also takes in neuromyelitis optica, autoimmune encephalitis and the immunology of the peripheral nerve.多发性硬化与神经免疫学共处一栏，视神经脊髓炎、自身免疫性脑炎与周围神经的免疫问题也归入其中。

• Dementia and neurodegenerative diseases occupy a section where Alzheimer's disease, the frontotemporal degenerations and the prion disorders are all treated.痴呆与神经退行性疾病另设一栏，阿尔茨海默病、额颞叶变性与朊蛋白病都在其中讨论。

• Headache and neurogenic pain make up a section given to migraine, cluster headache, trigeminal neuralgia and the persistent pain states that follow nerve injury.头痛与神经源性疼痛自成一栏，偏头痛、丛集性头痛、三叉神经痛与神经损伤后的持续疼痛状态均在其内。

• Neuro-oncology and neurosurgical oncology share a section, and papers on glioma biology, tumour imaging and the surgical handling of intracranial tumours appear there.神经肿瘤与神经外科肿瘤学共用一个栏目，胶质瘤生物学、肿瘤影像以及颅内肿瘤的外科处理都刊在这一栏。

• Neurocritical and neurohospitalist care has a section beside neurotrauma, covering intensive management, inpatient neurological consultation and traumatic injury of brain and spine.神经重症与神经住院照护设有独立栏目，与神经创伤相邻，覆盖重症管理、住院神经科会诊以及颅脑与脊髓创伤。

• Paediatric neurology and neurogenetics are separate sections, the second taking Mendelian disease, chromosomal disorders and the testing that identifies them.儿童神经病学与神经遗传学分设两栏，后者收孟德尔遗传病、染色体病以及用于识别它们的检测。

• Four sections sit on the borders of the field, for neuromuscular disorders and peripheral neuropathies, for autonomic disorders, for neuro-ophthalmology and for neuro-otology.另有四栏处在学科的边缘地带，分别管神经肌肉疾病与周围神经病、自主神经疾病、神经眼科与神经耳科。

• Cognitive and behavioural neurology and neurorehabilitation carry work on aphasia, neglect, apraxia and the recovery of function after injury.认知与行为神经病学、神经康复两栏，收录失语、忽视、失用以及损伤后功能恢复方面的稿件。

• Applied neuroimaging, artificial intelligence in neurology, neurotechnology and neurological biomarkers form a methodological cluster, in which imaging pipelines, learned models and fluid markers are tested against clinical endpoints.应用神经影像、神经病学人工智能、神经技术与神经生物标志物构成一个方法学集群，影像流程、学习模型与体液标志物都在其中对照临床终点接受检验。

• Neuroepidemiology and neuroinfectious diseases sit beside diagnostic neuropathology, the last taking biopsy and autopsy material from muscle, nerve and brain.神经流行病学与神经感染病学紧邻诊断神经病理学，最后一栏收肌肉、神经与脑的活检及尸检材料。

• Experimental therapeutics has a section to itself, open to preclinical drug work, early phase trials and the design of neurological outcome measures.实验治疗学独占一栏，接受临床前药物研究、早期试验以及神经科结局指标的设计。

• Article types run from Original Research, Review, Mini Review and Systematic Review through Brief Research Report, Clinical Trial, Methods, Study Protocol and Classification to Perspective, Opinion, Hypothesis and Theory, Data Report and Policy and Practice Reviews.文体从原创研究、综述、小型综述与系统综述，经简报、临床试验、方法、研究方案与分类，一直到观点、意见、假设与理论、数据报告以及政策与实践评论。

• Surgical technique on its own does not qualify, case reports are considered only in the neuro-ophthalmology section, and simple bibliometric surveys are no longer taken. Computational work on public data, NHANES or Mendelian randomisation among it, must carry validation, and systematic reviews are expected to follow PRISMA and to close on a point of neurological relevance.单纯的外科技术稿件不予受理，病例报告只在神经眼科栏目考虑，简单的文献计量调查已经停收。以公共数据为原料的计算研究，包括 NHANES 与孟德尔随机化一类，须附验证，系统综述则要求遵循 PRISMA 并落在神经科学相关的结论上。

History

• Volume 1 appeared in 2010, three years after the publisher itself had been set up, and the title has belonged to the open access series from its first number.第 1 卷出现在 2010 年，当时出版方成立不过三年，刊物自创刊号起即属于该社的开放获取丛书。

• Frontiers itself dates from 2007, when Henry Markram and Kamila Markram founded it in Lausanne as a not-for-profit foundation that ran at first on philanthropic money.Frontiers 本身始于 2007 年，由（Henry Markram）与（Kamila Markram）在洛桑创立为非营利基金会，最初依靠慈善捐助运转。

• The gold open access model was adopted in 2008, two years before this journal opened, and every title in the series has followed it since.金色开放获取模式在 2008 年确立，比本刊创刊早两年，此后丛书中的每一种刊物都沿用它。

• The National Library of Medicine records the imprint as Lausanne, Frontiers Research Foundation, 2010, the name the journal carried at the start. That name has since given way to Frontiers Media SA, which signs the copyright line of every article today.美国国立医学图书馆记下的出版项是洛桑的 Frontiers Research Foundation，2010 年，那是刊物起步时的名义。这一名义后来让位于 Frontiers Media SA，如今每篇文章的版权行都署这个名字。

• Only one ISSN was ever assigned, the electronic 1664-2295, since there is no print edition to number separately.刊物始终只有一个刊号，即电子版的 1664-2295，没有另编一版的印刷本需要单独编号。

• Deposits go to Crossref under the publisher's 10.3389 prefix, and each DOI carries the journal stem fneur, the year and the article number in that order.论文以出版方的 10.3389 前缀存入 Crossref，每篇文章的 DOI 依次由刊名代号、年份与文章编号构成。

• PubMed has carried the journal from volume 1 in 2010 and PubMed Central holds the full text, while MEDLINE came far later, from volume 17 in 2026.PubMed 自 2010 年第 1 卷起收录该刊，PubMed Central 存有全文，MEDLINE 迟至 2026 年第 17 卷才纳入。

• Volume numbering has run one to a year without a break, so volume 10 belongs to 2019, volume 16 to 2025 and volume 17 to 2026.卷号每年一卷，从未中断，第 10 卷属 2019 年，第 16 卷属 2025 年，第 17 卷属 2026 年。

• Growth has been on the scale of a megajournal. Themed Research Topics, in which guest editors gather a block of papers around one question, are how much of that material is assembled.增长幅度接近巨型刊。主题合集由客座编辑围绕单一问题组织一批论文，刊物相当一部分内容以这种方式结集。

• The impact factor moved from 4.086 in 2022 to 2.7 in 2023, 2.8 in 2024 and 3.3 in 2025, with a cited half-life of 4.3 years and roughly 1844 articles a year.影响因子从 2022 年的 4.086 落到 2023 年的 2.7，2024 年为 2.8，2025 年回升到 3.3，被引半衰期 4.3 年，年发文约 1844 篇。

• Journal Citation Reports puts it at 107 of 296 in clinical neurology and 156 of 330 in neurosciences, both second quartile, and counts 57716 citations to its papers.《期刊引证报告》把它列在临床神经病学的 107/296 与神经科学的 156/330，均属第二区，并统计到 57716 次引用。

• Some 99.82 per cent of what it publishes is gold open access, released under a CC BY licence that leaves copyright with the authors.刊出内容中约 99.82% 为金色开放获取，以 CC BY 许可发布，版权留在作者手中。

Editors

• Irene Litvan of the University of California, San Diego, in La Jolla, holds the post of Field Chief Editor and answers for the journal as a whole.（Irene Litvan）任职于拉霍亚的加利福尼亚大学圣迭戈分校，担任领域主编，对整本刊物负责。

• Below her the title divides into 27 specialty sections, each with a Specialty Chief Editor who takes the final view on manuscripts in that field.领域主编之下设有 27 个专业栏目，每栏各有一位栏目主编，对该领域的稿件作出最终判断。

• Diagnostic Neuropathology is led by Safa Al-Sarraj of King's College Hospital NHS Foundation Trust in London, and Movement Disorders by Alberto Albanese of the Catholic University of the Sacred Heart in Milano.诊断神经病理学由伦敦国王学院医院 NHS 基金会信托的（Safa Al-Sarraj）主持，运动障碍由米兰圣心天主教大学的（Alberto Albanese）主持。

• Stroke has Jean-Claude Baron of the University of Cambridge at its head, and multiple sclerosis and neuroimmunology has Hans-Peter Hartung of the Heinrich Heine University in Düsseldorf.卒中一栏以剑桥大学的（Jean-Claude Baron）为首，多发性硬化与神经免疫学一栏以杜塞尔多夫海因里希·海涅大学的（Hans-Peter Hartung）为首。

• Neurogenetics is led by Nobutaka Hattori of Juntendo University in Tokyo, and neuro-ophthalmology by Valérie Biousse of the Emory University School of Medicine in Atlanta.神经遗传学由东京顺天堂大学的（Nobutaka Hattori）主持，神经眼科由亚特兰大埃默里大学医学院的（Valérie Biousse）主持。

• Autonomic disorders are in the hands of William Polk Cheshire of the Mayo Clinic in Jacksonville, and cognitive and behavioural neurology in those of Jordan Grafman of the Shirley Ryan AbilityLab in Chicago.自主神经疾病交由杰克逊维尔梅奥诊所的（William Polk Cheshire）掌理，认知与行为神经病学交由芝加哥雪莉·瑞安能力实验室的（Jordan Grafman）掌理。

• Epilepsy carries two chiefs, Yvonne Höller of the University of Akureyri in Iceland and Julia Jacobs of the University of Calgary, while sleep disorders rest with Yuichi Inoue of Tokyo Medical University.癫痫一栏有两位主编，冰岛阿克雷里大学的（Yvonne Höller）与卡尔加里大学的（Julia Jacobs），睡眠障碍则归东京医科大学的（Yuichi Inoue）。

• Manuscripts go to a section rather than to the journal at large, and they are reviewed by the Associate Editors and community reviewers of that section. Case reports are taken only through neuro-ophthalmology, after a draft has been sent to the editorial office for pre-evaluation.稿件投往具体栏目而非整本刊物，由该栏的副编辑与社区评审人评审。病例报告只经神经眼科栏目接收，作者须先把稿本送到编辑部做预评估。

• The model is single anonymised. Reviewers are hidden from authors, authors are visible to reviewers, and the handling editor sees both.评审采用单盲模式，评审人身份不向作者透露，作者身份对评审人可见，处理编辑两方都知。

• Reviews run in two stages, an independent stage in which each reviewer works alone through a standard questionnaire, then an interactive forum in which authors and reviewers argue the revisions until a version is endorsed.评审分两段进行，先是独立评审，各评审人依标准问卷独自审读，随后进入互动论坛，作者与评审人就修改往复辩难，直到某一版本获得认可。

• Acceptance needs the unanimous agreement of the reviewers and the handling Associate Editor, and either side may call for arbitration if the exchange deadlocks. Editor and reviewer names with affiliations are printed on every published article, which is how a nominally anonymised system ends up signed.接收须经评审人与处理副编辑一致同意，往复陷入僵局时任一方都可提请仲裁。每篇刊出的文章都印有编辑与评审人的姓名及单位，名义上匿名的制度因此留下了署名。

• Article processing charges fall due only on acceptance, and institutions in the publisher's partnership programme cover them in whole or in part.文章处理费只在录用后计收，参加出版方机构合作计划的单位可全额或部分承担。

• The journal belongs to the Committee on Publication Ethics, and the platform keeps post-publication commenting and a community retraction procedure open to readers.该刊是出版伦理委员会的成员，平台对读者保留刊后评论与社区撤稿程序的入口。